In: Gut microbes, 2021, vol. 13, no. 1, p. 20
Intestinal microbiota regulates multiple host metabolic and immunological processes. Consequently, any difference in its qualitative and quantitative composition is susceptible to exert significant effects, in particular along the gut-liver axis. Indeed, recent findings suggest that such changes modulate the severity and the evolution of a wide spectrum of hepatobiliary disorders. However, the...
|
In: Seminars in Immunopathology, 2015, vol. 37, no. 2, p. 173-186
|
In: Supportive Care in Cancer, 2015, vol. 23, no. 7, p. 1837-1839
|
In: Brain, 2016, vol. 139, no. 9, p. 2503-2515
|
In: Journal of Perinatal Medicine, 2017, vol. 45, no. 5, p. 627-633
|
In: Breast Cancer Research and Treatment, 2015, vol. 149, no. 2, p. 449-460
|
In: Cerebral Cortex, 2018, vol. 28, no. 12, p. 4365-4378
|
In: Brain, 2017, vol. 140, no. 9, p. e57-e57
|
In: Cancers, 2020, vol. 12, no. 7, p. 17 p
Diffuse large B cell lymphoma (DLBCL) is a heterogenous disease that has been distinguished into at least two major molecular entities, the germinal center-like B cell (GCB) DLBCL and activated-like B cell (ABC) DLBCL, based on transcriptome expression profiling. A recurrent ch11q24.3 gain is observed in roughly a fourth of DLBCL cases resulting in the overexpression of two ETS transcription...
|
In: The breast, 2020, vol. 52, p. 110-115
Background: Corona Virus Disease 19 (COVID-19) had a worldwide negative impact on healthcare systems, which were not used to coping with such pandemic. Adaptation strategies prioritizing COVID-19 patients included triage of patients and reduction or re-allocation of other services. The aim of our survey was to provide a real time international snapshot of modifications of breast cancer...
|